Literature DB >> 28267380

Abscopal effect of metastatic pancreatic cancer after local radiotherapy and granulocyte-macrophage colony-stimulating factor therapy.

Fang Shi1, Xin Wang1,2, Feifei Teng1,3, Li Kong1, Jinming Yu1,3.   

Abstract

The role of immunotherapy in combination with traditional treatment regime in improving the survival of cancer patients has attracted more and more attention. Especially the abscopal effect that describes the phenomenon of localized radiotherapy leading to regression of distant unirradiated tumors and the role of enhanced radiotherapy-induced immunogenic cell death and activation of immune system have become a focus of the studies. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is known a powerful stimulator of the generation, migration and activation of antigen presenting cells such as dendritic cells (DC) and macrophages. Here we report a case of a 67-year-old refractory metastatic pancreatic cancer patient who obtained evident abscopal effect and survival benefit from concurrent localized radiotherapy and GM-CSF.

Entities:  

Keywords:  Abscopal effect; CD8+ T cell; GM-CSF; dentritic cell; hypofractionated radiation

Mesh:

Substances:

Year:  2017        PMID: 28267380      PMCID: PMC5389422          DOI: 10.1080/15384047.2016.1276133

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  20 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy.

Authors:  Mizuki Nishino; David M Jackman; Hiroto Hatabu; Beow Y Yeap; Leigh-Anne Cioffredi; Jeffrey T Yap; Pasi A Jänne; Bruce E Johnson; Annick D Van den Abbeele
Journal:  AJR Am J Roentgenol       Date:  2010-09       Impact factor: 3.959

Review 3.  Cell death modalities: classification and pathophysiological implications.

Authors:  L Galluzzi; M C Maiuri; I Vitale; H Zischka; M Castedo; L Zitvogel; G Kroemer
Journal:  Cell Death Differ       Date:  2007-04-13       Impact factor: 15.828

4.  PL03.05 An intergroup randomized phase III comparison of standard-dose (60 Gy) vs high-dose (74 Gy) chemoradiotherapy (CRT) +/- cetuximab (cetux) for stage III non-small cell lung cancer (NSCLC): results on cetux from RTOG 0617.

Authors: 
Journal:  Clin Adv Hematol Oncol       Date:  2014-01

5.  Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization.

Authors:  Neus Romo; Giuliana Magri; Aura Muntasell; Gemma Heredia; Diogo Baía; Ana Angulo; Monica Guma; Miguel López-Botet
Journal:  J Leukoc Biol       Date:  2011-07-08       Impact factor: 4.962

Review 6.  Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation - implications for cancer therapies.

Authors:  B Frey; Y Rubner; R Wunderlich; E-M Weiss; A G Pockley; R Fietkau; U S Gaipl
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 7.  Immunogenic cell death and DAMPs in cancer therapy.

Authors:  Dmitri V Krysko; Abhishek D Garg; Agnieszka Kaczmarek; Olga Krysko; Patrizia Agostinis; Peter Vandenabeele
Journal:  Nat Rev Cancer       Date:  2012-11-15       Impact factor: 60.716

Review 8.  Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination?

Authors:  Mitchell Kamrava; Michael B Bernstein; Kevin Camphausen; James W Hodge
Journal:  Mol Biosyst       Date:  2009-08-27

9.  Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions.

Authors:  Jan T Poleszczuk; Kimberly A Luddy; Sotiris Prokopiou; Mark Robertson-Tessi; Eduardo G Moros; Mayer Fishman; Julie Y Djeu; Steven E Finkelstein; Heiko Enderling
Journal:  Cancer Res       Date:  2016-02-01       Impact factor: 12.701

Review 10.  The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence.

Authors:  Holly E Barker; James T E Paget; Aadil A Khan; Kevin J Harrington
Journal:  Nat Rev Cancer       Date:  2015-07       Impact factor: 60.716

View more
  20 in total

Review 1.  The Reciprocity between Radiotherapy and Cancer Immunotherapy.

Authors:  Yifan Wang; Zhi-Gang Liu; Hengfeng Yuan; Weiye Deng; Jing Li; Yuhui Huang; Betty Y S Kim; Michael D Story; Wen Jiang
Journal:  Clin Cancer Res       Date:  2018-11-09       Impact factor: 12.531

Review 2.  Harnessing the Immune System in Pancreatic Cancer.

Authors:  Satya Das; Jordan Berlin; Dana Cardin
Journal:  Curr Treat Options Oncol       Date:  2018-08-20

Review 3.  Synergistic effects of radiotherapy and targeted immunotherapy in improving tumor treatment efficacy: a review.

Authors:  Tahir Bashir Dar; Fleury Augustin Nsole Biteghe; Ruchi Kakar-Bhanot; Eric Chekwebe Aniogo; Zaria Malindi; Olusiji Alex Akinrinmade; Nyangone Ekome Toung Chalomie; Arnaud John Kombe Kombe; Sophie Aboughe Angone; Jean Marc Ngome Ndong; Jean Delacroix Ndong
Journal:  Clin Transl Oncol       Date:  2022-08-01       Impact factor: 3.340

Review 4.  Chemoradiation and granulocyte-colony or granulocyte macrophage-colony stimulating factors (G-CSF or GM-CSF): time to think out of the box?

Authors:  Marouan Benna; Jean-Baptiste Guy; Claire Bosacki; Omar Jmour; Majed Ben Mrad; Oleksandr Ogorodniitchouk; Saïd Soltani; Meiling Lan; Elisabeth Daguenet; Benoîte Mery; Sandrine Sotton; Nicolas Magné; Alexis Vallard
Journal:  Br J Radiol       Date:  2020-02-04       Impact factor: 3.039

5.  The Abscopal Effect in the Era of Cancer Immunotherapy: a Spontaneous Synergism Boosting Anti-tumor Immunity?

Authors:  Zuzana Hlavata; Cinzia Solinas; Pushpamali De Silva; Michele Porcu; Luca Saba; Karen Willard-Gallo; Mario Scartozzi
Journal:  Target Oncol       Date:  2018-04       Impact factor: 4.493

6.  Potentiating Antitumor Efficacy Through Radiation and Sustained Intratumoral Delivery of Anti-CD40 and Anti-PDL1.

Authors:  Hsuan-Chen Liu; Dixita I Viswanath; Federica Pesaresi; Yitian Xu; Licheng Zhang; Nicola Di Trani; Jesus Paez-Mayorga; Nathanael Hernandez; Yu Wang; Donald R Erm; Jeremy Ho; Antonia Susnjar; Xuewu Liu; Sandra Demaria; Shu-Hsia Chen; Bin S Teh; Edward Brian Butler; Corrine Ying Xuan Chua; Alessandro Grattoni
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-08-05       Impact factor: 8.013

Review 7.  Radiotherapy in Combination With Cytokine Treatment.

Authors:  Ondrej Palata; Nada Hradilova Podzimkova; Eva Nedvedova; Alexandra Umprecht; Lenka Sadilkova; Lenka Palova Jelinkova; Radek Spisek; Irena Adkins
Journal:  Front Oncol       Date:  2019-05-22       Impact factor: 6.244

Review 8.  Exploring the Potential Utility of Pet Dogs With Cancer for Studying Radiation-Induced Immunogenic Cell Death Strategies.

Authors:  Timothy M Fan; Kimberly A Selting
Journal:  Front Oncol       Date:  2019-01-15       Impact factor: 6.244

Review 9.  Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions.

Authors:  Yifan Wang; Weiye Deng; Nan Li; Shinya Neri; Amrish Sharma; Wen Jiang; Steven H Lin
Journal:  Front Pharmacol       Date:  2018-03-05       Impact factor: 5.810

Review 10.  Abscopal Effect of Radiotherapy in the Immunotherapy Era: Systematic Review of Reported Cases.

Authors:  Nergiz Dagoglu; Sule Karaman; Hale B Caglar; Ethem N Oral
Journal:  Cureus       Date:  2019-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.